Search

Guizhou Hengchang Polymer Materials Co., Ltd. was established in 2017, with its registered address located in the Guanshanhu District of Guiyang City, Guizhou Province. It is a high-tech enterprise specializing in the research and development, production, and sales of polymer materials. The company’s core business encompasses R&D and industrialization of modified plastics, engineering plastics, specialty elastomers, and functional composite materials; its products are widely applied in automotive components, electronic/electrical housings, interior fittings for rail transit, green packaging, and structural components supporting new energy applications. Leveraging the Provincial Engineering Technology Research Center for Polymer Materials (approved under Document No. Qian Ke Han Gao Xin [2022] 37), the enterprise masters core technological processes including halogen-free flame-retardant blending modification, glass-fiber-reinforced weather-resistant formulation design, and low-VOC emission control. It holds six authorized invention patents and 19 utility model patents. The company possesses the “High-Tech Enterprise Certificate” (No. GR202352000286, valid until 2026), has passed ISO 9001:2015 Quality Management System Certification and IATF 16949:2016 Automotive Quality Management System Certification, and certain products have passed UL94 flammability certification as well as RoHS and REACH compliance testing. Representative projects include long-term supply of PP-T20 long-glass-fiber-reinforced bumper skeleton material to the Guizhou Geely Automobile Manufacturing Base (mass production supplied from 2022 to 2024); additionally, the company serves as the lead entity for the Guizhou Provincial “14th Five-Year Plan” Key New Materials Special Project titled “Pilot-Scale Application Research on Bio-Based Biodegradable Polymer Composites” (project approved in 2023). The company’s industrial and commercial registration status is “in operation,” with a stable number of employees covered by social insurance ranging between 80 and 110. Its service coverage extends across the manufacturing cluster in Southwest China, providing customized material solutions, joint technical development, and pilot-scale mass-production support to sectors including automotive, electronics, rail transit, new energy, and eco-friendly packaging.

Guizhou Furong Chemical Co., Ltd. is a regional, medium- and small-sized chemical R&D and trading enterprise established in 2017 and operating continuously and stably. Based in Guiyang, the company serves the entire country, focusing on the technological development, manufacturing, and market-oriented application of non-hazardous chemical reagents, auxiliaries, and chemical products. Its core business encompasses the manufacturing of chemical reagents and auxiliaries (excluding hazardous chemicals), R&D and sales of chemical products, and R&D of new materials. The company possesses independent qualifications for import and export of goods and technologies, demonstrating its compliance capabilities across the full R&D–production–distribution chain and its foundation for international collaboration. Leveraging its in-house R&D capacity, the company has accumulated stable technical expertise and product commercialization capabilities in the field of non-hazardous fine chemicals, enabling it to provide downstream manufacturing enterprises, research institutions, and new-materials application enterprises with customized R&D support, standardized product supply, and technical solutions. As a law-abiding entity registered as “in operation” in the National Enterprise Credit Information Publicity System, the company holds the Unified Social Credit Code 91520115MA6H0E7LX8, and all its operations strictly comply with the scope authorized by the state, without involvement in any activities related to hazardous chemicals. Current collaboration opportunities include: joint development and OEM/ODM supply of non-hazardous chemical reagents and auxiliaries; collaborative application technology development for new chemical materials; co-construction of import/export channels targeting domestic and international markets; and localized technical services and rapid-response support for the central and western regions of China.

Guiyang Kaiphosphorus Fertilizer Co., Ltd. is a backbone enterprise in Guizhou Province’s key phosphate chemical industry chain. Leveraging Guizhou Province’s abundant phosphate ore resources, the company specializes in the research and development, manufacturing, and sales of phosphate fertilizers. Its core business covers high-concentration ammonium phosphates (monoammonium phosphate and diammonium phosphate), compound fertilizers, and supporting phosphate chemical intermediates. Its products are widely applied in domestic staple crop cultivation, cash crop farming, and specialty agriculture. The company’s primary sales markets include Southwest China, South China, and the middle and lower reaches of the Yangtze River—the major grain-producing regions—and its products are exported to certain Southeast Asian countries via the Beibu Gulf Port in Guangxi. The company possesses an annual production capacity of 1.2 million tons of high-concentration ammonium phosphates and 600,000 tons of compound fertilizers. Its core production facilities employ mature and reliable technologies, including wet-process phosphoric acid purification, tubular reactor granulation, and distributed control system (DCS)-based full-process automatic control. Key process energy consumption and pollutant emissions comply with the “Emission Standards for Pollutants from Phosphate Fertilizer Industry” (GB 16171-2012) and Guizhou Province’s “14th Five-Year Plan” requirements for green manufacturing. The company has obtained certifications for ISO 9001 Quality Management System, ISO 14001 Environmental Management System, and ISO 45001 Occupational Health and Safety Management System; holds the National Industrial Product Production License (Fertilizer Category) and the Fertilizer Registration Certificate issued by the Ministry of Agriculture and Rural Affairs; operates a provincial-level enterprise technology center; participated in revising the industry standard “Diammonium Phosphate for Industrial Use” (HG/T 5043-2016); and owns five invention patents—including “An Anti-Caking Coating Agent for Diammonium Phosphate and Preparation Method Thereof”—and 12 utility model patents. Its technological achievements focus on enhancing phosphate fertilizer efficacy, controlled-release modification, and synergistic utilization of solid waste. Representative projects include undertaking the Guizhou Provincial Science and Technology Support Program titled “Key Technology Integration and Demonstration for Efficient and Clean Conversion of Medium-to-Low Grade Phosphate Ore,” and establishing a demonstration line for comprehensive utilization of phosphogypsum at its Kaiyang base. The “Kailin” brand diammonium phosphate has been selected consecutively for years into the “Top 100 Brands in China’s Fertilizer Industry.” The company offers multi-dimensional cooperation—including product supply, technical collaboration, customized compound fertilizer formulation development, demonstration projects for resource-oriented utilization of phosphogypsum, and co-development of green fertilizer solutions—with agricultural service enterprises, agro-input distributors, large-scale farms, scientific research institutions, and local governments.

Guiyang FinDreams Battery Co., Ltd. is a new-energy vehicle power battery and energy storage battery R&D, manufacturing, and sales enterprise fully owned by BYD Company Limited. It serves as one of BYD’s core production bases for “Blade Batteries” and undertakes a key capacity deployment mission in Southwest China. The company specializes in lithium-ion battery manufacturing, battery component production, sales of new-energy vehicle electrical accessories, and energy storage technical services. Its products primarily support BYD’s Dynasty and Ocean series flagship vehicle models and supply BYD’s vehicle assembly plants in Xi’an, Hefei, and Changzhou; some products are exported to overseas BYD factories in Brazil, Thailand, and Uzbekistan. Leveraging BYD’s self-developed technology system, the production lines have fully adopted the structural innovation technology of the “Blade Battery” and the CTB (Cell-to-Body) integration process. The company has secured 37 invention patents and utility model patents (as of January 2025) in fields including cell structural optimization, precision control of electrode sheet slitting, and module thermal management design. The company has obtained certifications for the IATF 16949 Automotive Quality Management System, ISO 14001 Environmental Management System, and ISO 45001 Occupational Health and Safety Management System, and holds internationally recognized battery safety and transportation certifications such as UL, UN38.3, and CE. As a key project under Guizhou Province’s “14th Five-Year Plan” for new-type industrialization and as a provincial-level green factory in 2023, the company is deeply integrated into BYD’s four-city battery industry collaboration network—Guiyang–Changsha–Xi’an–Shenzhen—and collaborates with Guizhou’s local phosphorus chemical industry chain on raw materials, conducting pilot cooperation on lithium iron phosphate precursor materials. Currently, the company focuses exclusively on providing vertically integrated battery supply to the BYD Group and does not engage in third-party contract manufacturing or independent brand sales to external customers; its collaboration efforts center on new-energy vehicle OEM fitment, energy storage system integration support, and localized industrial chain coordination.

Lonza Guangzhou Pharmaceutical Ltd. is a wholly owned subsidiary of the Swiss Lonza Group AG established in China, specializing in Contract Development and Manufacturing Organization (CDMO) services for the pharmaceutical industry. It positions itself as a specialized small-molecule drug development and manufacturing partner serving global innovative pharmaceutical companies and biotechnology firms. The company’s core business includes customized research and development as well as commercial-scale manufacturing of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and highly potent active pharmaceutical ingredients (HPAPIs). Its services span the entire spectrum from preclinical development through to commercialization, supporting applications such as oral solid dosage forms, sterile injectables, and highly sensitizing products. Core capabilities encompass process development ranging from gram-scale to ton-scale, impurity profiling, polymorph screening, validation of continuous manufacturing processes, and operation of dedicated production lines for highly potent compounds. Its technology platforms support rapid translation of innovative drugs and their large-scale delivery. The company holds a “Pharmaceutical Production License” (Category Code: D) issued by China’s National Medical Products Administration (NMPA). Its Guangzhou manufacturing site passed the NMPA’s on-site Good Manufacturing Practice (GMP) inspection in 2018 and complies with international guidelines including ICH Q7, Q9, and Q10. Certain APIs have obtained Certificates of a Suitability of the Monograph (CEP) issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM), and relevant products have completed Drug Master File (DMF) submissions with the U.S. Food and Drug Administration (FDA). Leveraging Lonza’s global quality management system, the company has achieved ISO 9001:2015 certification and participates in China’s national key R&D program “Major New Drug Creation,” specifically its industrialization collaboration initiative. Typical collaborations include supplying Phase III clinical trial APIs for anti-tumor candidate drugs to Biotech companies listed on China’s STAR Market, and providing long-term supply of key intermediates for central nervous system (CNS) drugs to leading European multinational pharmaceutical companies. Its service network is anchored in South China, extends across the entire country, and integrates into Lonza’s Asia-Pacific and global supply chain systems, delivering end-to-end CDMO partnerships—from process development and regulatory filing support to commercial manufacturing—for domestic and international pharmaceutical companies, biotech firms, and research institutions.

Guangzhou Kansai Paint Co., Ltd. was established in 1993 as a Sino-foreign joint venture jointly invested by Kansai Paint Co., Ltd. (Japan) and Guangzhou Industrial Development Group Co., Ltd. Its registered address is located in Huangpu District, Guangzhou City, Guangdong Province. It is one of Kansai Paint’s earliest production bases established in China, with both its registered capital and paid-in capital amounting to USD 18 million. The company is currently operational.  

The company specializes in industrial coatings, with core business activities covering B2B industrial coating solutions, including automotive original equipment manufacturer (OEM) painting, automotive refinish coatings (RECOAT), rail transit vehicle coating, protective coatings for construction machinery and steel structures, among others. Its industry classification is “Specialized Coating Manufacturing” (National Economic Industry Classification C2641). Leveraging Kansai Paint’s global R&D system, the company possesses continuous industrialization capabilities in environmentally friendly coating technologies, such as water-based systems, high-solids coatings, low-temperature baking, and primerless processes.  

The Guangzhou factory has obtained certifications for ISO 9001 Quality Management System, ISO 14001 Environmental Management System, and IATF 16949 Automotive Quality Management System, and holds relevant supporting qualifications for China’s Compulsory Certification (CCC). Some products comply with GB/T 38597–2020 “Technical Requirements for Low-Volatile Organic Compound Content Coating Products” and the EU REACH Regulation.  

The company provides OEM coating services to leading automobile manufacturers in South China, including GAC Honda, GAC Toyota, and Dongfeng Nissan. It has participated in coating projects for multiple lines of the Guangshen-Hong Kong High-Speed Railway and Guangzhou Metro. Its “KCC” brand automotive refinish coatings are distributed across over 2,000 authorized body & paint centers nationwide.  

As one of Kansai Paint’s three core production bases in China, Guangzhou Kansai serves as a hub in South China for supply chain responsiveness, localized technical service delivery, and VOCs emission reduction initiatives. Its international business operations are conducted collaboratively through Kansai Paint’s global sales network, delivering customized coating materials and technical support to automobile manufacturers, rail transit equipment manufacturers, construction machinery enterprises, steel structure engineering firms, and end-user repair service providers.

Findreams Battery Guangxi Asean Co., Ltd. is a high-tech manufacturing enterprise wholly owned by FinDream Battery Co., Ltd., a subsidiary of BYD Company Limited. The company is positioned as the core production base for new-energy power batteries in the China–ASEAN region, providing deep support to China’s national strategies of “Western Development” and “China–ASEAN Industrial Collaboration.” Its primary business encompasses research & development, manufacturing, and sales of lithium-ion power battery cells, modules, and PACKs, covering the full technical spectrum of lithium iron phosphate (LFP) batteries. Its core technologies originate from BYD’s Blade Battery system, and it holds independent intellectual property rights—including optimized cell structures, integrated thermal management systems, and high-safety electrolyte formulations—with related patents publicly disclosed (e.g., CN114725332A, CN115275237A). Its products are widely applied in new-energy vehicle powertrain systems and have passed China’s mandatory product certification (CCC), UN38.3 transportation safety certification, and the series of national standards for power batteries (GB/T 31484–31486); the company is also listed as an approved battery supplier in the “Recommended Vehicle Models Catalog for New-Energy Vehicle Promotion and Application.” The enterprise has established an annual production capacity of 20 GWh for power batteries; its Phase I project commenced operations in October 2023, achieving an automation rate exceeding 95% and possessing full-chain, automotive-grade mass-production capability. It has obtained certifications under ISO 9001, ISO 14001, and IATF 16949. Currently, the company primarily supplies batteries to BYD’s Nanning Base and整车 manufacturers across South and Southwest China; leveraging the Regional Comprehensive Economic Partnership (RCEP) and the China–ASEAN Free Trade Area policies, it exports power battery modules to ASEAN countries—including Thailand, Indonesia, and Malaysia—to support local new-energy bus and passenger vehicle projects. It offers diverse forms of collaboration—including joint R&D, customized manufacturing, collaborative testing, localized supply-chain partnerships, and technology commercialization—with OEMs, energy storage system integrators, battery material and component suppliers, and technical consulting firms.

Guangji Pharmaceutical (Jining) Co., Ltd. is a wholly owned subsidiary established in 2019 by Hubei Guangji Pharmaceutical Co., Ltd. (Stock Code: 000952.SZ) in the Caohe Town Industrial Park, Yanzhou District, Jining City, Shandong Province, with registered capital of RMB 150 million. It serves as a pivotal production base under Guangji Pharmaceutical’s strategic layout of “One Headquarters, Multiple Bases,” focusing on large-scale production and green manufacturing upgrades of vitamin B2 (riboflavin) and its key intermediates. The company’s core business encompasses research and development, production, and sales of food-grade and feed-grade vitamin B2; its products are widely applied by major domestic feed enterprises and food additive manufacturers, and are exported via the parent company to Southeast Asia, South America, and the Middle East. Leveraging its independently developed “microbial fermentation—directional crystallization—refined purification” process, the company demonstrates significant advantages in energy consumption control, product yield, and environmental friendliness; related technologies have been incorporated into Guangji Pharmaceutical’s “Key Green Biomanufacturing Technologies for Riboflavin” system. The enterprise has obtained certifications for ISO 9001 Quality Management System, ISO 22000 Food Safety Management System, and FAMI-QS European Feed Additive Quality System; it holds a Feed Additive Production License (Lu Si Tian [2022] T0332) and a Food Production License (SC12737088202595). Its project has received environmental impact assessment approval from the Shandong Provincial Department of Ecology and Environment (Lu Huan Shen [2020] No. 18) and completed environmental protection acceptance. The Jining base has a designed annual production capacity of 3,000 metric tons, making it Guangji Pharmaceutical’s second-largest riboflavin production base; it commenced formal operations in 2022 and is currently undergoing continuous capacity ramp-up. Areas of collaboration include customized supply of vitamin B2, technical cooperation in feed and food sectors, joint application of green processes, and OEM/ODM manufacturing services compliant with international quality standards.

Guangdong Zhongzhan Fusion Technology Research Co., Ltd. is a high-tech enterprise specializing in “intelligent sensing + edge computing + industry-integrated applications,” focusing on three vertical scenarios: industrial internet, smart cities, and digital energy. The company provides embedded intelligent terminals with integrated software-hardware synergy, multi-source heterogeneous data fusion platforms, and customized AIoT solutions. It possesses robust technical expertise, with core technologies including the low-power wide-area sensor networking protocol ZHF-Link, the lightweight edge AI inference framework FusionEdge v2.3, and the cross-platform device semantic interoperability middleware FusionBridge. The company has been granted 7 invention patents, 12 utility model patents, and 31 software copyrights; its R&D investment accounted for 28.6% of revenue in 2023. In terms of certifications, the company has obtained ISO 9001:2015 Quality Management System Certification and ISO/IEC 27001:2022 Information Security Management System Certification; holds Grade II qualification for electronic and intelligent engineering contracting (Guangdong Construction Market Qualification No. [2023] 1876); and has acquired Information Security Risk Assessment Service Qualification from the China Cybersecurity Review Technology and Certification Center (CCRC) (Certificate No.: CCRC-2024-ISV-0892). In December 2024, it was recognized as a Guangdong Province “Specialized, Refined, Distinctive, and Innovative” (Zhuan Jing Te Xin) SME. Project implementations span multiple provincial key projects, including the Guangdong Provincial Energy Administration’s “Distributed Photovoltaic Intelligent Monitoring Pilot Project,” the “Smart Park IoT Infrastructure Construction Project” in Nanhai District, Foshan City (awarded in 2024 with a contract value of RMB 12.68 million), and the “Bulk Cargo Terminal Equipment Health Diagnostic System” for Zhanjiang Port Group (delivered in January 2025). The company offers full-lifecycle AIoT collaboration services—including technical consulting, system integration, platform deployment, customized development, and ongoing operation & maintenance—to government and enterprise clients nationwide.

Guangdong Jingyun Electronic Materials Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and sales of electronic-grade functional materials, positioned as a key material supplier for semiconductor packaging and electronic component manufacturing. The company’s core business covers the manufacturing and sales of electronic specialty materials, with a focus on niche products including underfill adhesives for semiconductor packaging, chip-level electrically conductive/thermally conductive adhesives, and coverlay adhesives for flexible printed circuits (FPCs). Its technical approach is based on self-modified epoxy resin systems integrated with nanofiller dispersion and rheological control processes; its products feature low stress, high heat resistance (Tg ≥ 150°C), and halogen-free environmental compliance. The company primarily serves domestic midstream and downstream packaging-and-test (P&T) facilities and module manufacturers. It has obtained ISO 9001:2015 Quality Management System certification and was officially recognized as a High-Tech Enterprise by the Guangdong Provincial Department of Science and Technology in December 2023 (Certificate No. GR202344007821), valid for three years. As of mid-2025, the company holds three authorized invention patents and five utility model patents; related technological achievements have already been applied in certain domestic substitution projects. Its customer base includes multiple Tier-2 P&T enterprises located in cities such as Foshan and Dongguan, emphasizing supply-chain collaboration within the South China region. The company emphasizes both independent R&D and process optimization, possessing full-process technical capabilities—from formulation design and laboratory-scale verification to pilot-scale production—in the field of electronic specialty materials. It offers customized adhesive material development, process compatibility support, and small-batch validation cooperation to P&T enterprises, module manufacturers, and materials integrators.